Page 92 - GTM-4-2

Global Translational Medicine Angiotensinogen in liver steatosis

doi: 10.3389/fimmu.2022.834606 IIalpha in chromosome instability and personalized cancer
therapy. Oncogene. 2015;34:4019-4031.
60. Chen YC, Chen IS, Huang GJ, et al. Targeting DTL
induces cell cycle arrest and senescence and suppresses cell doi: 10.1038/onc.2014.332
growth and colony formation through TPX2 inhibition in 67. El Dika M, Dudka D, Kloc M, Kubiak JZ. CDC6 as a key
human hepatocellular carcinoma cells. Onco Targets Ther. inhibitory regulator of CDK1 activation dynamics and the timing
2018;11:1601-1616.
of mitotic entry and progression. Biology (Basel). 2023;12:855.
doi: 10.2147/OTT.S147453
doi: 10.3390/biology12060855
61. Jia W, Liu X, Zhang Z. Role of TOP2A and CDC6 in liver 68. Fesler A, Zhang N, Ju J. The expanding regulatory universe
cancer. Medicine (Baltimore). 2023;102:e35604.
of p53 in gastrointestinal cancer. F1000Res. 2016;5:756.
doi: 10.1097/MD.0000000000035604
doi: 10.12688/f1000research.8363.1
62. Wang K, Jiang X, Jiang Y, et al. EZH2-H3K27me3-mediated 69. Song B, Wang Y, Titmus MA, et al. Molecular mechanism
silencing of mir-139-5p inhibits cellular senescence in of chemoresistance by miR-215 in osteosarcoma and colon
hepatocellular carcinoma by activating TOP2A. J Exp Clin cancer cells. Mol Cancer. 2010;9:96.
Cancer Res. 2023;42:320.
doi: 10.1186/1476-4598-9-96
doi: 10.1186/s13046-023-02855-2
70. Revill K, Wang T, Lachenmayer A, et al. Genome-wide
63. Ramos-Santillan V, Oshi M, Nelson E, Endo I, Takabe K. methylation analysis and epigenetic unmasking identify
High Ki67 gene expression is associated with aggressive tumor suppressor genes in hepatocellular carcinoma.
phenotype in hepatocellular carcinoma. World J Oncol. Gastroenterology. 2013;145:1424-1435.e1421-1425.
2024;15:257-267.
doi: 10.1053/j.gastro.2013.08.055
doi: 10.14740/wjon1751
71. Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y. Single-cell RNA
64. Jin J, Valanejad L, Nguyen TP, et al. Activation of CDK4 sequencing technologies and applications: A brief overview.
triggers development of non-alcoholic fatty liver disease. Clin Transl Med. 2022;12:e694.
Cell Rep. 2016;16:744-756.
doi: 10.1002/ctm2.694
doi: 10.1016/j.celrep.2016.06.019
72. Tobar Leitao SA, Soares DDS, Carvas Junior N, Zimmer R,
65. Denechaud PD, Lopez-Mejia IC, Giralt A, et al. E2F1 Ludwig NF, Andrades M. Study of anesthetics for euthanasia
mediates sustained lipogenesis and contributes to hepatic in rats and mice: A systematic review and meta-analysis on
steatosis. J Clin Invest. 2016;126:137-150.
the impact upon biological outcomes (SAFE-RM). Life Sci.
doi: 10.1172/JCI81542 2021;284:119916.
66. Chen T, Sun Y, Ji P, Kopetz S, Zhang W. Topoisomerase doi: 10.1016/j.lfs.2021.119916

Volume 4 Issue 2 (2025) 84 doi: 10.36922/gtm.6027